Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome: A Randomized Trial Comparing Brain-Gut Directed VR vs. Sham VR

NCT06257472 is registered in ClinicalTrials.gov with Anthony Lembo as lead sponsor.

NCT NCT06257472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Virtual Reality (VR) for Irritable Bowel Syndrome: A Randomized Trial Comparing Brain-Gut Directed VR vs. Sham VR
Lead sponsor
Anthony Lembo
Phase
Not applicable
Overall status
Withdrawn
Start date
December 31, 2024
Completion date
August 31, 2025
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ibs - irritable bowel syndrome